SB 248-FN (2024): relative to bail for a defendant.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“SB 248-FN (2024): relative to bail for a defendant.” Granite Record, https://graniterecord.org/bill/2024/sb248. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). SB 248-FN (2024): relative to bail for a defendant. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2024/sb248
Chicago
Granite Record. “SB 248-FN (2024): relative to bail for a defendant.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2024/sb248.
BibTeX
@misc{bill-2024-sb248, title = {SB 248-FN (2024): relative to bail for a defendant.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2024/sb248}, note = {Accessed 24 Oct. 2026} }

SB 248-FN (2024)

relative to bail for a defendant.

  • Status: Referred for interim study
  • Term: 2023-2024
  • House committee: Criminal Justice and Public Safety
  • Senate committee: Judiciary
  • Subject: Crimes, Criminal Procedure and Corrections

The Story

It was introduced on January 19, 2023 and referred to the Senate Judiciary committee. The committee held a public hearing on February 1, 2023. The committee voted unanimously, 5–0, to recommend that the Senate send it back to committee, and the report was placed on the consent calendar. On February 22, 2023 the Senate voted to send it back to committee on a voice vote. The committee voted 4–1 to recommend that the Senate pass it. On January 3, 2024 the Senate voted to pass it on a voice vote, then referred it on to the Senate Finance committee. The committee voted unanimously, 6–0, to recommend that the Senate pass it. On February 15, 2024 the Senate voted to pass it on a voice vote and ordered it to a third reading. It crossed to the House on February 22, 2024 and was referred to the House Criminal Justice and Public Safety committee. The committee held a public hearing on March 20, 2024, with 7 people signed in online: 3 in support and 4 in opposition. The committee met in executive session on April 10, 2024 and April 24, 2024. The committee voted unanimously, 20–0, to recommend that the House study it after the session ends, and the report was placed on the regular calendar. On May 2, 2024 the House voted to study it after the session ends on a voice vote. The committee held a work session on September 19, 2024. The committee met in executive session on September 19, 2024 to vote on its recommendation. The committee reported back on its interim study of the bill: “Not Recommended for Future Legislation”, by a vote of 17 to 0.

Sponsors

Hearings and Sessions

  • February 1, 2023, 1:15 PM: hearing, Senate Judiciary, SH 100
  • March 20, 2024, 1:00 PM: public hearing, House Criminal Justice and Public Safety, LOB 202-204
  • April 10, 2024, 1:00 PM: executive session, House Criminal Justice and Public Safety, LOB 202-204
  • April 24, 2024, 11:00 AM: executive session, House Criminal Justice and Public Safety, LOB 202-204
  • September 19, 2024, 10:00 AM: full committee work session, House Criminal Justice and Public Safety, LOB 202-204
  • September 19, 2024, 1:00 PM: executive session, House Criminal Justice and Public Safety, LOB 202-204

Votes

  • February 22, 2023, Senate: Rereferred to Committee — voice vote, passed
  • January 3, 2024, Senate: Ought to Pass — voice vote, passed
  • February 15, 2024, Senate: Ought to Pass — voice vote, passed
  • May 2, 2024, House: Refer for Interim Study — voice vote, passed

The Docket

  • January 19, 2023: Introduced 01/19/2023 and Referred to Judiciary
  • February 1, 2023: Hearing: 02/01/2023, Room 100, SH, 01:15 pm
  • February 22, 2023: Committee Report: Rereferred to Committee, 02/22/2023; Vote 5-0; CC
  • February 22, 2023: Rereferred to Committee, MA, VV; 02/22/2023
  • January 3, 2024: Committee Report: Ought to Pass, 01/03/2024, Vote 4-1
  • January 3, 2024: Ought to Pass: MA, VV; Refer to Finance Rule 4-5; 01/03/2024
  • February 15, 2024: Committee Report: Ought to Pass, 02/15/2024, Vote 6-0
  • February 15, 2024: Ought to Pass : MA, VV; OT3rdg; 02/15/2024
  • February 22, 2024: Introduced (in recess of) 02/22/2024 and referred to Criminal Justice and Public Safety
  • March 20, 2024: Public Hearing: 03/20/2024 01:00 pm LOB 202-204
  • April 10, 2024: Executive Session: 04/10/2024 01:00 pm LOB 202-204
  • April 19, 2024: ==CANCELLED== Executive Session: 04/19/2024 09:30 am LOB 202-204
  • April 24, 2024: Executive Session: 04/24/2024 11:00 am LOB 202-204
  • April 24, 2024: Committee Report: Refer for Interim Study 04/24/2024 (Vote 20-0; RC)
  • May 2, 2024: Refer for Interim Study: MA VV 05/02/2024
  • September 19, 2024: Full Committee Work Session: 09/19/2024 10:00 am LOB 202-204
  • September 19, 2024: Executive Session: 09/19/2024 01:00 pm LOB 202-204
  • October 31, 2024: Interim Study Report: Not Recommended for Future Legislation (Vote 17-0)

Laws It Would Change

Related Bills

  • HB 1476-FN (2022): relative to release of a defendant pending trial.
  • HB 1661-FN-LOCAL (2022): relative to regional career technical education agreements, an appropriation for preliminary work for a new legislative parking garage, health and human services, establishing an extraordinary need grant for schools, training and procedures for zoning and planning boards, and financial investments and incentives for affordable housing development.
  • HB 610-FN (2023): expanding the definition of providers who can certify patients of the therapeutic cannabis program and relative to release of a defendant pending trial and relative to product labeling and information guide requirements for cannabis products and the prohibition of the sale of hemp products containing certain levels of THC.
  • HB 1476-FN (2022): relative to release of a defendant pending trial.
  • HB 610-FN (2023): expanding the definition of providers who can certify patients of the therapeutic cannabis program and relative to release of a defendant pending trial and relative to product labeling and information guide requirements for cannabis products and the prohibition of the sale of hemp products containing certain levels of THC.

From the General Court